The role of p53 deficiency or mutation in regulating nonhistone protein crotonylation and its impact on cancer development remain unclear.
The present study identified crotonylation as a therapeutic target in patients with p53 deficiency or mutation in colorectal cancer.
Crotonylome analysis revealed that p53 deficiency upregulated heterogeneous nuclear ribonucleoprotein C (HNRNPC) and HNRNPC
